
VRTX Technical Analysis Summary (NASDAQ)
Analyze VRTX on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerVRTX Technical Analysis Summary (NASDAQ)
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Vertex Pharmaceuticals Incorporated on the NASDAQ is awaiting a decisive move. Technical conditions suggest Vertex Pharmaceuticals Incorporated is consolidating, awaiting a decisive move.
RSI (14): 49.38
Stochastic %K: 32.48
Williams %R: -58.79
Rate of Change (ROC): 0.21
Takeaway:Vertex Pharmaceuticals Incorporated shows neutral momentum, with indicators pointing to indecision.
MACD: 0.43
ADX: 16.24
ATR (14): 13.92
CCI (14): -47.52
Takeaway:Vertex Pharmaceuticals Incorporated shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Vertex Pharmaceuticals Incorporated trades around the middle band, reflecting balanced price action.
Takeaway:Vertex Pharmaceuticals Incorporated trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:VRTX shows balanced money flow with a slight bearish tilt.
Bullish Signals
MACD above 0 → bullish trend confirmation.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for Vertex Pharmaceuticals Incorporated are mixed, suggesting a Hold or wait-and-see approach.